CoChat

Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype

Open access

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Mutations in the rhodopsin gene cause retinal degeneration and clinical phenotypes including retinitis pigmentosa (RP) and congenital stationary night blindness. Effective gene therapies have been difficult to develop, however, because generating precise levels of rhodopsin expression is critical; overexpression causes toxicity, and underexpression would result in incomplete rescue. Current gene delivery strategies routinely use cDNA‐based vectors for gene targeting; however, inclusion of noncoding components of genomic DNA (gDNA) such as introns may help promote more endogenous regulation of gene expression. Here we test the hypothesis that inclusion of genomic sequences from the rhodopsin gene can improve the efficacy of rhodopsin gene therapy in the rhodopsin knockout (RKO) mouse model of RP. We utilize our compacted DNA nanoparticles (NPs), which have the ability to transfer larger and more complex genetic constructs, to deliver murine rhodopsin cDNA or gDNA. We show functional and structural improvements in RKO eyes for up to 8 months after NP‐mediated gDNA but not cDNA delivery. Importantly, in addition to improvements in rod function, we observe significant preservation of cone function at time points when cones in the RKO model are degenerated. These results suggest that inclusion of native expression elements, such as introns, can significantly enhance gene expression and therapeutic efficacy and may become an essential option in the array of available gene delivery tools.— Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., Naash, M. I. Genomic DNA nanoparticles rescue rhodopsin‐associated retinitis pigmentosa phenotype. FASEB J. 29, 2535‐2544 (2015). www.fasebj.org

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.15-270363

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 55

Metadata

Authors
Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., & Naash, M. I.
Affiliations
  • University of Oklahoma Health Sciences Center (US)
  • Copernicus Therapeutics (United States) (US)
Corresponding author
Han, Zongchao
Venue
The FASEB Journal
Publisher
Wiley
Published
2015-02-24
Volume
29
Issue
6
Pages
2535-2544
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2013410637
Cited by
54
References
43
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 2 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 3 · 2015: 5
FWCI
2.89
Type
journal article
Language
en
Open access
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (R21EY024059‐ZH, EY018656‐MIN, EY22778‐MIN, EY018137‐MRA)
  • Oklahoma Center for the Advancement of Science and Technology
  • Knights Templar Eye Foundation
  • Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina - Chapel Hill
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
retinitis pigmentosa, rhodopsin, gene therapy, DNA nanoparticles, introns, retinal degeneration, rod photoreceptors, cone photoreceptors, gene expression regulation, congenital stationary night blindness
MeSH terms
Animals, Disease Models, Animal, DNA, Gene Expression Regulation, Humans, Introns, Phenotype, Retina, Retinitis Pigmentosa, Rhodopsin, Blotting, Western, Reproducibility of Results, Genetic Therapy, Gene Transfer Techniques, Mice, Knockout, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, Microscopy, Electron, Transmission, Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. https://app.cochat.ai/papers/10.1096/fj.15-270363
The paper
Han, Z., Banworth, M. J., Makkia, R., Conley, S. M., Al‐Ubaidi, M. R., Cooper, M. J., & Naash, M. I. (2015). Genomic DNA nanoparticles rescue rhodopsin-associated retinitis pigmentosa phenotype. The FASEB Journal. https://doi.org/10.1096/fj.15-270363

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.